@article{articleb287c77b,
title   = {First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial},
author = {Babiker, A. and Castro nee Green, H. and Compagnucci, A. and Fiscus, S. and Giaquinto, C. and Gibbs, D. and Harper, L. and Harrison, L. and Hughes, H. D. and McKinney, R. and Melvin, A. and Mofenson, L. and Saidi, Y. and Smith, M. E. and Tudor-Williams, G. and Walker, A. S. and Mussi-Pinhata, Marisa Márcia},
year = {2011},
doi = {10.1016/S1473-3099(10)70313-3},
journal   = {The Lancet Infectious Diseases}
}